The annual meeting will focus on acute myeloid leukemia, acute promeyelocytic leukemia, acute lymphoblastic leukemia, chronic myeloid leukemia, myelodysplastic syndrome and multiple myeloma.
International and national experts will present the critical appraisal of emerging and existing data and its applicability in the day to day practice. An important focus of this meeting will be the trainees' education with the help of multi-disciplinary sessions addressing the diagnosis, prognostication and therapy of hematological cancers.
This meeting will showcase the data on acute leukemia's from the Indian centers.
The poster session will provide an opportunity to present data pertaining to diagnosis, treatment, novel finding and clinical outcomes in hematology cancers.
The unique aspect is the opportunity to showcase novel research concepts and ideas relevant to the country.
Hematology Cancer Consortium is a multi-center collaborative academic organization established with the aim to improve knowledge, standardize cost-effective treatment strategies and promote regionally relevant research in hematological cancers. In the first year of its existence the consortium has established collaborative database for the acute leukemia's and has started the process for conducting prospective investigator-initiated studies.
